Test Price
2,800 AED✅ Home Collection Available
DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Genetic Counselling by DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test employs Next-Generation Sequencing to detect pathogenic variants in the PARK19 locus, confirming a hereditary form of parkinsonism that typically manifests before age 21. This test is critical for accurate diagnosis, family risk assessment, and guiding long-term neurological care.
| Feature | Our Test (DNAJC6 NGS) | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Precision | >99.9% sensitivity, full gene coverage | Limited to known hotspots |
| Methodology | Next-Generation Sequencing (NGS) | Sanger sequencing / targeted panel |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Type | Blood, Extracted DNA, or FTA Card | Blood only |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I emphasize that this genetic test confirms the molecular basis of juvenile-onset Parkinson disease but must always be correlated with clinical findings and a detailed three-generation pedigree. A positive result indicates a genetic predisposition, while a negative result does not exclude other genetic or idiopathic forms. Please discuss all results with your treating neurologist or genetic counsellor before making any clinical decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory & Exclusion Criteria
Do not discontinue prescribed medications without consulting your treating physician. The results of this test may influence medication decisions, but any changes must be supervised.
Exclusion Criteria: Inability to provide a blood or DNA sample after adequate attempts, lack of informed consent, or individuals under legal guardianship without proper authorization.
ER Red Flags: Acute psychiatric symptoms, rapid neurological deterioration, or any acute medical crisis – seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the DNAJC6 gene test and who should consider it?
The DNAJC6 NGS test analyzes the entire PARK19 gene to detect variants causing juvenile-onset Parkinson disease. It is recommended for individuals with early-onset parkinsonian symptoms (before age 21), a positive family history, or unexplained movement disorders.
2. How is the test performed and how long do results take?
A simple blood draw, a drop of blood on an FTA card, or an extracted DNA sample is collected. Results are typically available within 3 to 4 weeks using high-throughput NGS technology.
3. What do the results mean for my health and my family?
A positive result confirms a genetic susceptibility to juvenile-onset Parkinson disease and enables early intervention and family screening. A negative result reduces but does not eliminate the possibility of another genetic or idiopathic form of parkinsonism.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Lab Accreditation: ISO 9001:2015 certified (INT/EGQ/2509DA/3139). DNA Labs UAE is a DHA-licensed facility operating under License No. 1143.
Clinical & Logistical Metadata
| Test Name | DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | G20 (Parkinson's disease) |
| LOINC Code | 21676-3 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians